DIMINISHED ABILITY OF ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS TO LIMIT OPSONIZED IMMUNE-COMPLEX DEPOSITION ON LEUKOCYTES AND ACTIVATION OF GRANULOCYTES
Ch. Nielsen et al., DIMINISHED ABILITY OF ERYTHROCYTES FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS TO LIMIT OPSONIZED IMMUNE-COMPLEX DEPOSITION ON LEUKOCYTES AND ACTIVATION OF GRANULOCYTES, Arthritis and rheumatism, 41(4), 1998, pp. 613-622
Objective. To compare the ability of normal erythrocytes and erythrocy
tes from systemic lupus erythematosus (SLE) patients to bind immune co
mplexes (IC), thereby inhibiting IC deposition on polymorphonuclear le
ukocytes (PMN) and the consequent induction of a PMN respiratory burst
(RE), Methods. The binding of fluorescein isothiocyanate-labeled IC i
n 75% autologous serum to whole blood cells or isolated leukocytes fro
m 17 SLE patients and 10 controls was assessed by flow cytometry, Reac
tive oxygen metabolite (ROM) production by PMN was measured as the int
racellular oxidation of dihydro-rhodamine 123, on stimulation with unl
abeled IC. Results, Erythrocyte-mediated inhibition of IC uptake by PM
N reached a mean +/- SD maximum of 68 +/- 18% in controls and 29 +/- 5
1% in SLE patients (P < 0.05) and, in the patients, correlated inverse
ly with disease activity, In the presence of erythrocytes from various
donors, IC binding to a standard preparation of PMN and their ROM pro
duction were inversely proportional to the number of type 1 complement
receptors (CR1) per donor erythrocyte. Thus, the ROM production was h
igher in the presence of SLE patients? erythrocytes (125 +/- 67 CR1/er
ythrocyte) than with erythrocytes from controls (235 +/- 118 CR1/eryth
rocyte). Conclusion. Erythrocytes from SLE patients are defective in p
rotecting their PMN against IC deposition and induction of the RB.